Haupt Pharma - Drug Development, Clinical Trial Supplies and Contract Manufacturing

Haupt Pharma is one of Europe’s leading contract manufacturers for pharmaceutical products with seven production sites in Germany, France, Malta and Japan. Haupt Pharma provides tailor-made solutions for nearly all dosage forms and several special products (sexual hormones, thyroid hormones, narcotics, cytostatics).

Haupt Pharma offers full service from pharmaceutical development and production of clinical trial supplies to regulatory affairs, full-scale contract manufacturing, packaging and logistics.

HAUPT PHARMA BERLIN GMBH - SOLID DOSAGE FORMS

Haupt Pharma’s headquarters as well as a production site with 180 employees is located in Berlin. Haupt Pharma Berlin develops and produces pharmaceuticals, herbals and food supplement products in solid dosage forms such as granulates, tablets, film-coated tablets, sugar-coated tablets, dry syrup and hard capsules.

Modern equipment and a well-structured organisation guarantee an efficient and reliable service.

HAUPT PHARMA BRACKENHEIM GMBH - BLISTER PACKAGING

Haupt Pharma Brackenheim’s speciality is blister packaging. This modern high-tech plant with its team of 80 employees ensures that your pharmaceuticals are expertly packaged and on their way to your customers on time.

More than 300 deep-draw format sets are at your disposal to meet all individual requirements. The annual production is 200 million blisters in finished packs. In addition, clinical trial packaging is offered by specialists located in Brackenheim.

HAUPT PHARMA LIVRON SAS - STERILE AMPOULES, HARD CAPSULES, SUPPOSITORIES

Haupt Pharma Livron is p rimarily responsible for the demanding French pharmaceutical market. Haupt Pharma’s French site offers a completely renovated production facility and state-of-the-art equipment. The 165 employees at Haupt Pharma Livron develop and produce liquid sterile products in ampoules as well as hard capsules and suppositories.

HAUPT PHARMA MALTA LTD. – HIGH-POTENT SOLID DOSAGE FORMS

In September 2007 Haupt Pharma started a co-operation with Siegfried Generics in Malta. The production site is a brand new site for solid dosage forms with a separate dedicated area for high-potent substances.

The site enables Haupt Pharma to manufacture products for early markets and ensures supply of sufficient launch quantities for new generic products.

HAUPT PHARMA MÜNSTER GMBH - HORMONES AND NARCOTICS

The production site in Münster concentrates on development and high-quality, on-time contract manufacturing of oral high-potency, low-dose products (contraceptives, thyroid hormones and narcotics in entirely separate areas. Competent packaging of solids in blisters and bottles is also available.

150 employees produce tablets, film-coated tablets, sugar-coated tablets, liquids and suspensions.

HAUPT PHARMA TORIDE CO., LTD. - PARENTERALS

At the Toride production site 30 employees manufacture sterile drugs in 1ml - 5ml ampoules. A special feature is the microwave sterilization.

Toride production site is Haupt Pharma’s strategic platform to improve the company’s access to the Japanese market.

HAUPT PHARMA WOLFRATSHAUSEN GMBH – SERILE PRODUCTS, CYTOTOXICS

The production plant in Wolfratshausen is known for its isolator technology for sterile products. 250 employees carry out the development and production of most pharmaceutical dosage forms including sterile products / parenterals (ampoules / vials), liquids, ointments, gels, suspensions, suppositories, granulates, tablets and hard capsules.

Special products manufactured here include lab-scale formulation batches and medicinal products with cytostatic agents and narcotics.

HAUPT PHARMA DEVELOPMENT GMBH - PARTNER FOR PHARMACEUTICAL DEVELOPMENT PROJECTS

Haupt Pharma Development coordinates and performs development projects for various dosage forms. The services include analytical and formulation development, process validation, pilot scale production and stability studies.

The technical equipment is state-of-the-art. Separated working areas allow the handling of toxic and other critical active substances. The experienced development team stands for reliable results and a time and cost-efficient development approach.